Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Nitrosamine Impurity Risk in Intermediates: Guide
This guide explains three formation pathways (amine + nitrite reaction, recovered solvent contamination, and shared-equipment cross-contamination), walks through the CPCA classification framework for assessing risk ...
Read More →
Intermediate Retest Date vs Expiry Date: What Buyers Must Know
This guide clarifies the three terms (retest date, expiry date, shelf life) with ICH definitions, explains how manufacturers assign retest periods using a risk-based stability ...
Read More →
Intermediate Pricing: 6 Cost Drivers Explained
A manufacturer's guide to the six cost layers behind pharmaceutical intermediate pricing—raw materials, synthesis yields, chiral chemistry, purification, waste treatment, and scale—helping buyers evaluate competing ...
Read More →
LCZ696 Intermediate Synthesis: Key Building Blocks & Quality Control for Sacubitril/Valsartan Production
A guide to LCZ696 intermediate synthesis: the five-step route, key quality control parameters, and co-crystal purity requirements for consistent API performance.
Read More →